Verve Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Verve Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $5.2M | 370k | 13.94 |
2023-09-30 | $4.8M | 363k | 13.26 |
2023-06-30 | $6.3M | 335k | 18.75 |
2023-03-31 | $4.6M | 322k | 14.42 |
2022-12-31 | $6.2M | 321k | 19.35 |
2022-09-30 | $11M | 307k | 34.35 |
2022-06-30 | $2.2M | 145k | 15.28 |
2022-03-31 | $3.5M | 154k | 22.83 |
2021-12-31 | $3.9M | 105k | 36.88 |
2021-09-30 | $4.8M | 103k | 47.01 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management